The pathology of rheumatic diseases and rheumatic diseases is systemic inflammatory disorders caused by autoinflammation and autoimmune responses, and a significant progress of inflammation science and rheumatology made diagnostic technique, a therapeutic drug, and therapy develop remarkably. On the contrary, in Japan, the regional disparities in the medical system are still large, and there are a lot of problems that should be solved. At first, regarding the solutions to such problems in pediatric rheumatic diseases, we need to investigate the actual situations and find the problems in specific regions; it is necessary to build medical care network taking regional characteristics in consideration in order to improve the medical quality in Japan. In addition, based on a long-term prospect, it is crucial to classify and manage each of problems surrounding patients, such as those on transitional care for chronic diseases, the cooperation with the parent association in Japan, and medical cost.